Amneal to Participate at Upcoming Investor Conferences in June
Amneal Pharmaceuticals (NASDAQ: AMRX) has announced its participation in two major investor conferences in June 2025. The company will present at the Jefferies Global Healthcare Conference on June 5 at 9:20 AM ET and participate in a fireside chat at the Goldman Sachs Global Healthcare Conference on June 10 at 10:40 AM ET.
Co-CEO and President Chirag Patel and CFO Tasos Konidaris will represent Amneal at both events. Investors can access live webcasts through the company's investor relations website, with replay options available after the events.
Amneal Pharmaceuticals (NASDAQ: AMRX) ha annunciato la sua partecipazione a due importanti conferenze per investitori nel giugno 2025. L'azienda presenter脿 al Jefferies Global Healthcare Conference il 5 giugno alle 9:20 ET e parteciper脿 a una discussione informale al Goldman Sachs Global Healthcare Conference il 10 giugno alle 10:40 ET.
Il Co-CEO e Presidente Chirag Patel e il CFO Tasos Konidaris rappresenteranno Amneal in entrambi gli eventi. Gli investitori potranno seguire le dirette streaming tramite il sito web delle relazioni con gli investitori dell'azienda, con la possibilit脿 di rivedere le registrazioni dopo gli eventi.
Amneal Pharmaceuticals (NASDAQ: AMRX) ha anunciado su participaci贸n en dos importantes conferencias para inversores en junio de 2025. La compa帽铆a presentar谩 en la Jefferies Global Healthcare Conference el 5 de junio a las 9:20 AM ET y participar谩 en una charla informal en la Goldman Sachs Global Healthcare Conference el 10 de junio a las 10:40 AM ET.
El Co-CEO y Presidente Chirag Patel y el CFO Tasos Konidaris representar谩n a Amneal en ambos eventos. Los inversores podr谩n acceder a las transmisiones en vivo a trav茅s del sitio web de relaciones con inversores de la compa帽铆a, con opciones de repetici贸n disponibles despu茅s de los eventos.
Amneal Pharmaceuticals (NASDAQ: AMRX)電� 2025雲� 6鞗旍棎 鞐措Μ電� 霊� 臧滌潣 欤检殧 韴瀽鞛� 旎嵓霟办姢鞐� 彀胳棳頃� 瓴冹澊霛缄碃 氚滍憸頄堨姷雼堧嫟. 須岇偓電� 6鞗� 5鞚� 鞓れ爠 9鞁� 20攵�(霃欕秬鞁滉皠)鞐� Jefferies Global Healthcare Conference鞐愳劀 氚滍憸毳� 歆勴枆頃橂┌, 6鞗� 10鞚� 鞓れ爠 10鞁� 40攵�(霃欕秬鞁滉皠)鞐愲姅 Goldman Sachs Global Healthcare Conference鞐愳劀 雽�雼挫棎 彀胳棳頃╇媹雼�.
Co-CEO 瓴� 靷灔鞚� Chirag Patel鞕� CFO Tasos Konidaris臧� 霊� 頄夓偓鞐� 氇憪 彀胳劃頃橃棳 Amneal鞚� 雽�響滍暊 鞓堨爼鞛呺媹雼�. 韴瀽鞛愲摛鞚� 須岇偓鞚� 韴瀽鞛� 甏�瓿� 鞗轨偓鞚错姼毳� 韱淀暣 靸濎瓿勳棎 鞝戩啀頃� 靾� 鞛堨溂氅�, 頄夓偓 頉� 雼れ嫓氤搓赴 靹滊箘鞀る弰 鞝滉车霅╇媹雼�.
Amneal Pharmaceuticals (NASDAQ: AMRX) a annonc茅 sa participation 脿 deux grandes conf茅rences pour investisseurs en juin 2025. La soci茅t茅 pr茅sentera lors de la Jefferies Global Healthcare Conference le 5 juin 脿 9h20 ET et participera 脿 une discussion informelle lors de la Goldman Sachs Global Healthcare Conference le 10 juin 脿 10h40 ET.
Le Co-CEO et Pr茅sident Chirag Patel ainsi que le CFO Tasos Konidaris repr茅senteront Amneal lors des deux 茅v茅nements. Les investisseurs pourront acc茅der aux webdiffusions en direct via le site des relations investisseurs de la soci茅t茅, avec des options de replay disponibles apr猫s les 茅v茅nements.
Amneal Pharmaceuticals (NASDAQ: AMRX) hat seine Teilnahme an zwei bedeutenden Investorenkonferenzen im Juni 2025 angek眉ndigt. Das Unternehmen wird am Jefferies Global Healthcare Conference am 5. Juni um 9:20 Uhr ET pr盲sentieren und am Goldman Sachs Global Healthcare Conference am 10. Juni um 10:40 Uhr ET an einem Fireside Chat teilnehmen.
Co-CEO und Pr盲sident Chirag Patel sowie CFO Tasos Konidaris werden Amneal bei beiden Veranstaltungen vertreten. Investoren k枚nnen die Live-Webcasts 眉ber die Investor-Relations-Website des Unternehmens verfolgen, mit der M枚glichkeit, die Aufzeichnungen nach den Veranstaltungen anzusehen.
- None.
- None.
BRIDGEWATER, N.J., May 29, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) will participate in two upcoming investor conferences: Jefferies Global Healthcare Conference on June 5, 2025, with company presentation at 9:20 AM ET, and Goldman Sachs Global Healthcare Conference on June 10, 2025, with fireside chat at 10:40 AM ET. Chirag Patel, Co-Chief Executive Officer and President, and Tasos Konidaris, Executive Vice President and Chief Financial Officer, will participate in both conferences. A live webcast will be accessible at with replays available following both events.
About Amneal
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), headquartered in Bridgewater, NJ, is a global biopharmaceutical company. We make healthy possible through the development, manufacturing, and distribution of a diverse portfolio of over 280 pharmaceuticals, primarily within the United States. In its Affordable Medicines segment, the Company is expanding across a broad range of complex product categories and therapeutic areas, including injectables and biosimilars. In its Specialty segment, Amneal has a growing portfolio of branded pharmaceuticals focused primarily on central nervous system and endocrine disorders. Through its AvKARE segment, the Company is a distributor of pharmaceuticals and other products for the U.S. federal government, retail, and institutional markets. For more information, please visit聽 and follow us on .
Investor Contact
Anthony DiMeo
VP, Investor Relations
FAQ
When is Amneal Pharmaceuticals (AMRX) presenting at the Jefferies Global Healthcare Conference 2025?
What time is AMRX's fireside chat at the Goldman Sachs Global Healthcare Conference 2025?
Who will represent Amneal Pharmaceuticals at the June 2025 investor conferences?
How can investors access Amneal's (AMRX) conference presentations in June 2025?
